OSSIO is an orthopedic fixation company committed to transforming the orthopedic experience for patients, physicians and payors. Founded in 2014, its vision is to provide the first credible replacement to metal implants in the multi-billion-dollar global orthopedic fixation market with its OSSIOfiberTM Intelligent Bone Regeneration Technology. OSSIO's development headquarters is located in Caesarea, Israel, and its commercial headquarters is in Woburn, Massachusetts.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 03/11/19 | $22,000,000 |
OCV Partners Ortho Vision Secocha Ventures | undisclosed |
